ICP.TO Stock News Ic Potash Corp (ICP.TO) 0.28 08/01/2014 01

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ic Potash Corp (ICP.TO) 0.28 $ICP.TO

IC Potash Announces Results of 2014 Annual Meeting of Shareholders
Marketwire - Thu Jun 05, 2:12AM CDT
IC Potash Corp. ("ICP" or the "Company" (TSX: ICP) (OTCQX: ICPTF) today announced the results of the voting at its annual general meeting of shareholders (the "Meeting" , held on May 30, 2014 in Toronto, Ontario, Canada.

REMINDER: IC Potash to Host Q1 2014 Conference Call on Sulphate of Potash Fertilizer Ochoa Project
Marketwire - Tue Mar 11, 6:02AM CDT
IC Potash Corp. (TSX: ICP) (OTCQX: ICPTF) ("ICP" or the "Company" is pleased to announce it will host a conference call on Wednesday, March 12, 2014 at 10:30 a.m. EDT to discuss its 100%-owned Sulphate of Potash ("SOP" Ochoa Project located in southeast New Mexico, U.S.A.

IC Potash Announces Filing of Feasibility Study for the Ochoa Sulphate of Potash Project
Marketwire - Mon Mar 10, 6:01AM CDT
IC Potash Corp. (TSX: ICP) (OTCQX: ICPTF) ("ICP" or the "Company" is pleased to announce the filing of the "NI 43-101 Technical Report, Ochoa Project Feasibility Study, Lea County, New Mexico, USA" (the "Report" on SEDAR (www.sedar.com). The Report is also filed on the Company website (www.icpotash.com). The date of the Report is March 7, 2014, with an effective date of January 9, 2014. It was prepared by Qualified Persons from Agapito Associates Inc. and SNC-Lavalin Inc. All dollar amounts in this press release are U.S. dollars and all tons are short tons.

IC Potash to Host Q1 2014 Conference Call on Sulphate of Potash Fertilizer Ochoa Project
Marketwire - Fri Mar 07, 12:19PM CST
IC Potash Corp. (TSX: ICP) (OTCQX: ICPTF) ("ICP" or the "Company" is pleased to announce it will host a conference call on Wednesday, March 12, 2014 at 10:30 a.m. EDT to discuss its 100%-owned Sulphate of Potash ("SOP" Ochoa Project located in southeast New Mexico, U.S.A.

IC Potash Announces Publication of Final Environmental Impact Statement
Marketwire - Wed Mar 05, 6:02AM CST
IC Potash Corp. (TSX: ICP) (OTCQX: ICPTF) ("ICP" or the "Company" announced today the successful conclusion of the final Environmental Impact Statement (the "FEIS" for its 100%-owned Sulphate of Potash ("SOP" Ochoa Project ("Project" located in southeast New Mexico, U.S.A.

IC Potash to Advance Ochoa SOP Project on Positive Feasibility Study Results
Marketwire Canada - Thu Jan 23, 6:00AM CST
IC Potash Corp. (TSX: ICP) (OTCQX: ICPTF) -- Sidney Himmel, President and Chief Executive Officer of IC Potash Corp. ("ICP" or the "Company" , announced today the successful conclusion of an independent feasibility study ("Study" for its 100%-owned sulphate of potash ("SOP" Ochoa Project ("Project" located in southeast New Mexico. All dollar amounts in this press release are U.S. dollars and all tons are short tons.

Global Biocides Market Report to 2018: Halogen Compounds, Metallic Compounds, Organosulfurs, Organic Acids, Phenolic, Nitrogen and Others
M2 - Fri Jan 17, 8:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/7jx484/biocides_market) has announced the addition of the "Global Biocides Market Report to 2018" report to their offering. Biocides with huge application in water treatment and industries, as well as in households, are expected to experience substantial growth in future. The growing population and treated water demand are expected to influence the biocide market. Other growing applications such as paints and coatings are also expected to fuel the biocide market growth. This study provides analysis and forecasts the global biocide market from the demand side in terms of revenues (USD million) from 2011 to 2018. The report also analyzes several market driving and restraining factors along with their impact over the forecast period. The study provides a detailed view of the biocide market, by analyzing the key segments of product and applications. The report provides analysis of each product and application segment and forecasts the market in terms of revenue (USD million) from 2012 to 2018. The report also segments the market based on key geographies including North America, Europe, Asia Pacific and Rest of the World. The report further provides market volumes and revenue for each product and application segment under each regional segment. Based on biocide applications, the reports analysis attractiveness of each segment with the help of attractiveness tool. The study also includes value chain analysis for better understanding of the key players in the supply chain right from the raw material manufacturer to the end user. The study also provides a comprehensive view of the market using Porter's five forces analysis. Scope of the Report Application Segment Analysis - Water Treatment - Food and Beverages - Personal Care - Wood Preservation - Paint and Coatings - Other Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Biocides - Industry Analysis Chapter 4 Biocides Market - Product Segment Analysis Chapter 5 Specialty Biocide Market - Application Segment Analysis Chapter 6 Global Biocide Market - Regional Analysis Chapter 7 Company Profiles - AkzoNobel NV - Albemarle Corporation - Arch Chemicals Inc - Ashland Inc - BASF SE - Champion Technologies - Clariant AG - Lanxess - Lubrizol - THOR Group Limited - The Dow Chemical Company - Troy Corporation For more information visit http://www.researchandmarkets.com/research/7j...des_market

Treu Is in True Puzzle
by William Njuguna - All Africa Global Media - Thu Jan 16, 9:10AM CST
Kenya Sevens head coach Paul Treu has a selection headache at his hands following the return to full fitness of former skipper Humphrey Kayange, Oscar Ouma and Dennis Ombachi.

The Southern Sun Skal Networking Luncheon
by Joel Magu - All Africa Global Media - Thu Jan 16, 9:10AM CST
The Southern Sun Hotel Nairobi recently hosted the monthly Skal networking luncheon.

IC Potash Announces Publication of Draft Environmental Impact Statement for Ochoa Sulphate of Potash Project
Marketwire Canada - Mon Aug 12, 6:00AM CDT
IC Potash Corp. ("ICP" or the "Company" (TSX: ICP) (OTCQX: ICPTF) today announced that the Notice of Availability of the Draft Environmental Impact Statement ("DEIS" for the Ochoa Sulphate of Potash ("SOP" Project in southeastern New Mexico was published by the U.S. Department of the Interior Bureau of Land Management (BLM) in the Federal Register Friday, August 9, 2013.

IC Potash Expands Technical Team With Appointment of Richard "Dick" Beauchamp as Chief Mine Engineer
Marketwire - Wed Jul 10, 6:30AM CDT
IC Potash Corp. ("ICP" or the "Company" (TSX: ICP) (OTCQX: ICPTF) is pleased to announce the appointment of Richard Beauchamp, P.E. as Chief Mine Engineer of the Company's Ochoa Sulphate of Potash (SOP) Project in southeastern New Mexico.

IC Potash Announces Results of 2013 Annual and Special Meeting of Shareholders
Marketwire Canada - Mon Jul 01, 6:00AM CDT
IC Potash Corp. ("ICP" or the "Company" (TSX: ICP) (OTCQX: ICPTF) today announced the results of the voting at its annual and special meeting of shareholders (the "Meeting" , held on June 28, 2013 in Toronto, Ontario, Canada.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading